ICU Medical, Inc. (NASDAQ:ICUI) Shares Sold by Wellington Management Group LLP

Wellington Management Group LLP reduced its holdings in ICU Medical, Inc. (NASDAQ:ICUI - Free Report) by 84.5% in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 145,374 shares of the medical instruments supplier's stock after selling 792,122 shares during the quarter. Wellington Management Group LLP owned approximately 0.59% of ICU Medical worth $22,558,000 as of its most recent filing with the Securities and Exchange Commission.

Several other large investors have also recently added to or reduced their stakes in ICUI. Harvest Fund Management Co. Ltd purchased a new stake in ICU Medical in the 4th quarter valued at about $33,000. Murphy & Mullick Capital Management Corp acquired a new position in ICU Medical during the fourth quarter worth approximately $52,000. Venturi Wealth Management LLC increased its position in ICU Medical by 64.0% during the fourth quarter. Venturi Wealth Management LLC now owns 528 shares of the medical instruments supplier's stock worth $82,000 after purchasing an additional 206 shares during the last quarter. Smartleaf Asset Management LLC boosted its holdings in shares of ICU Medical by 166.8% in the 4th quarter. Smartleaf Asset Management LLC now owns 907 shares of the medical instruments supplier's stock valued at $140,000 after purchasing an additional 567 shares during the last quarter. Finally, Coldstream Capital Management Inc. acquired a new stake in shares of ICU Medical during the 3rd quarter worth $227,000. 96.10% of the stock is currently owned by hedge funds and other institutional investors.

Analyst Ratings Changes

ICUI has been the subject of a number of research reports. Needham & Company LLC reissued a "hold" rating on shares of ICU Medical in a research report on Tuesday. Raymond James set a $97.00 price objective on shares of ICU Medical in a research report on Wednesday, March 12th. Finally, StockNews.com upgraded shares of ICU Medical from a "hold" rating to a "buy" rating in a report on Friday, April 4th. One equities research analyst has rated the stock with a hold rating, three have assigned a buy rating and one has assigned a strong buy rating to the company. According to MarketBeat.com, the company currently has a consensus rating of "Buy" and a consensus target price of $168.67.

Remove Ads

ICU Medical Stock Up 3.0 %

NASDAQ:ICUI traded up $4.22 during trading hours on Friday, hitting $142.65. The stock had a trading volume of 318,377 shares, compared to its average volume of 269,086. The business has a 50 day simple moving average of $148.29 and a two-hundred day simple moving average of $160.95. ICU Medical, Inc. has a 1-year low of $93.36 and a 1-year high of $196.26. The company has a current ratio of 2.29, a quick ratio of 1.03 and a debt-to-equity ratio of 0.75. The company has a market cap of $3.50 billion, a PE ratio of -31.21 and a beta of 0.86.

About ICU Medical

ICU Medical, Inc, together with its subsidiaries, develops, manufactures, and sells medical devices used in infusion therapy, vascular access, and vital care applications worldwide. Its infusion therapy products include needlefree products under the MicroClave, MicroClave Clear, and NanoClave brands; Neutron catheter patency devices; ChemoClave and ChemoLock closed system transfer devices, which are used to limit the escape of hazardous drugs or vapor concentrations, block the transfer of environmental contaminants into the system, and eliminates the risk of needlestick injury; Tego needle free connectors; Deltec GRIPPER non-coring needles for portal access; and ClearGuard, SwabCap, and SwabTip disinfection caps.